Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2015 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Preferred Dividend Payments for 4 consecutive years, with $54.0 million the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Preferred Dividend Payments fell 16.92% year-over-year to $54.0 million; the trailing twelve-month figure through Dec 2018 stood at $249.0 million (down 4.23% YoY), and the FY2018 full-year result was $249.0 million, down 4.23% from the prior year.
• Preferred Dividend Payments slipped to $54.0 million in Q4 2018 per TEVA's latest filing, from $65.0 million in the prior quarter.
• Across five years, Preferred Dividend Payments topped out at $66.0 million in Q1 2016 and bottomed at $15.0 million in Q4 2015.
• Historically, Preferred Dividend Payments has averaged $60.4 million across 4 years, with a median of $65.0 million in 2016.
• The sharpest annual moves came in 2016 and 2018: Preferred Dividend Payments surged 333.33% in 2016, then declined 16.92% in 2018.
• Over 4 years, Preferred Dividend Payments stood at $15.0 million in 2015, then soared by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then slipped by 16.92% to $54.0 million in 2018.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered $54.0 million, $65.0 million, and $65.0 million for Q4 2018, Q3 2018, and Q2 2018 respectively.